Importantly, all PDXs retained their hormone receptor status throughout the experiment, PDXs that expressed ER, PR and/or HER2 in the original PDX continued to express these receptors in primary and metastatic tumours produced developed in this humanised model (Additional file 2: Figure S2). The gene discussed is ERBB2; the disease is neoplasm.